Skip to main content

Table 1 Baseline characteristics of NOMED-AF and Polish population

From: Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study

Clinical characteristics DM− DM+ p
NOMED-AF population Polish population NOMED-AF population Polish population
n [%] % (95% CI) n [%] % (95% CI)
Age overall 77.5 ± 8.06 74.5 ± 7.59 77.6 ± 7.54 75.1 ± 7.2 0.076
 65–69 years 430 [20] 35 (32.8–36.9) 142 [16] 27 (23.6–30.9) < 0.001
 70–74 years 435 [20] 22 (20.3–23.9) 197 [22] 26 (23.1–29.1) 0.020
 75–79 years 396 [19] 16 (15.1–17.5) 189 [21] 20 (17.4–22.1) 0.027
 80–84 years 361 [17] 13 (12.1–14.7) 168 [19] 15 (13.1–17.7) 0.166
 85–89 years 324 [15] 9 (8.3–9.7) 118 [13] 8 (6.6–10) 0.458
 ≥ 90 years 187 [9] 5 (4.2–5) 67 [8] 4 (3.2–4.7) 0.434
Female 1070 [50] 62 (60.3-63.9) 409 [46] 57 (53.5–60.4) 0.009
BMI (kg/m2) 27.33 ± 4.560 27.50 ± 4.625 29.77 ± 4.949 30.35 ± 4.981 < 0.001
Hypertension 1623 [77] 76 (74–77.8) 810 [92] 93 (91.8–94.7) < 0.001
Heart failure 431 [20] 16 (14.2–17.2) 242 [28] 25 (22.5–28.3) < 0.001
Chronic kidney disease (eGFR < 60ml/min) 524 [29] 24 (21.8–25.4) 285 [37] 32 (29.2–35.9) < 0.001
Chronic kidney disease (TOTAL) 641 [31] 24 (22.6–26) 364 [42] 37 (33.5–39.9) < 0.001
Haemodialysis 3[2] 1 (0.4–2.8) 5 [5] 3 (1–7.4) 0.458
Stroke 165 [8] 7 (5.–7.8) 118 [13] 13 (10.8–15) < 0.001
Ischemic cerebral stroke 124 [6] 5 (4.1–5.8) 82 [9] 9 (7.1–10.3) < 0.001
Intracranial haemorrhage 12 [1] 1 (0.3-1) 4 [0.5] 1 (0.2-2) 0.634
Unclassified stroke 29 [1] 1 (1-1.8) 32 [4] 3 (2.4-4.9) < 0.001
TIA 121 [6] 5 (3.8-5.4) 65 [7] 7 (5.4-9.2) 0.006
Coronary heart disease 392 [19] 16 (14.9–18.3) 274 [31] 29 (26.5–32.6) < 0.001
Myocardial infarction 253 [12] 10 (9.2–11.7) 193 [22] 21 (18.7–24.3) < 0.001
Peripheral artery disease 268 [13] 11 (9.5–11.9) 147 [17] 15 (12.7–17.1) < 0.001
CHA2DS2VASc (points) 3.60 ± 1.416 3.44 ± 1.384 5.08 ± 1.400 4.97 ± 1.414 < 0.001
CHA2DS2VASc in AF patients 4.12 ± 1.542 3.97 ± 1.591 5.49 ± 1.372 5.47 ± 1.444 < 0.001
CHA2DS2VASc in SAF patients 3.87 ± 1.543 3.74 ± 1.591 5.56 ± 1.450 5.57 ± 1.531 < 0.001
  1. AF: atrial fibrillation; BMS: body mass index; CHA2DS2-VASc: stroke risk scale (congestive heart failure, hypertension, age > 75, diabetes, stroke, vascular disease, age 65–74, sex); eGFR: estimated glomerular filtration rate; TIA: transient ischemic attack; SAF: silent atrial fibrillation
  2. Bold value indicates in the table are considered to be statistically significant (p < 0.05)